The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGEHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)The Zacks Analyst Blog Highlights: Procter & Gamble, Enterprise Products, UBS, Cintas and OGEZacks Equity ResearchZacksJanuary 2, 2020ReblogShareTweetShareFor Immediate ReleaseChicago, IL –January 2, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Procter & Gamble Company PG, Enterprise Products Partners L.P. EPD, UBS Group AG UBS, Cintas Corp. CTAS and OGE Energy Corp. OGE.Here are highlights from Tuesday’s Analyst Blog:Top Analyst Reports for Procter & Gamble, Enterprise Products and UBSThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company, Enterprise Products Partners (EPD) and UBS Group. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Procter & Gamble’s shares have outperformed the Zacks Soap and Cleaning Materials industry over the past one-year period (+35.4% vs. +21.8%).The company’s solid first-quarter fiscal 2020 results, wherein both top and bottom lines not only surpassed the Zacks Consensus Estimate but also improved year over year, is driving the stock momentum.Strong organic sales growth, backed by higher shipment volume and favorable price/mix, boosted the top line. Again, ongoing cost-saving and productivity efforts cushioned margins and in turn the bottom line.However, the company’s significant international presence exposes it to foreign currency risks, which have been weighing on the company’s performance.(You can read the full research report on Procter & Gamble here >>>)Shares of Enterprise Products have gained +13.3% in the past one-year period against the Zacks Oil and Gas - Production Pipeline - MLB industry’s rise of +4.2%. Enterprise Products boasts an extensive network of pipeline that spreads across nearly 50,000 miles. Importantly, this network is connected to every major U.S. shale play, and provides services to producers and users of various commodities.Notably, the partnership is well positioned to generate additional cash flow from $9.1 billion worth of growth capital projects – including the Midland & ECHO storage expansions – that are currently under construction. However, the partnership’s levered balance sheet can restrict its financial flexibility.(You can read the full research report on Enterprise Products here >>>)UBS Group’s shares have outperformed the Zacks Banks - Foreign industry over the past three-month period (+13.0% vs. +7.0%). The company continues to execute restructuring initiatives to free resources and invest in profitable areas to service clients with greater dexterity, improving quality and speed to market.Further, the company's cost-saving plans will aid the bottom-line expansion. Moreover, UBS Group AG remains focused on building capital levels and undertaking global-expansion initiatives.However, appreciation of the Swiss franc against other currencies is a headwind. Further, unsustainable capital-deployment activities keep us apprehensive.(You can read the full research report on UBS Group here >>>)Other noteworthy reports we are featuring today include Cintas Corp. and OGE Energy Corp.Today's Best Stocks from Zacks Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.See their latest picks free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com              https://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Story continuesWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report OGE Energy Corporation (OGE) : Free Stock Analysis Report Enterprise Products Partners L.P. (EPD) : Free Stock Analysis Report UBS Group AG (UBS) : Free Stock Analysis Report Cintas Corporation (CTAS) : Free Stock Analysis Report Procter & Gamble Company (The) (PG) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment ResearchReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoHow Does China Grand Pharmaceutical and Healthcare Holdings Limited (HKG:512) Stand Up To These Simple Dividend Safety Checks?Simply Wall St.Most face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDow Jones Futures Fall As Coronavirus Stock Market Correction Intensifies; Tesla, Nvidia, Beyond Meat Down LateInvestor's Business DailyBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceBankrupt Boy Scouts may need to sell Norman Rockwell art to pay sexual abuse victimsUSA TODAYSomething 'dangerous' is happening beneath the surface of the market selloffYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo Finance